These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34229249)

  • 21. NT79: A novel neurotensin analog with selective behavioral effects.
    Boules M; Liang Y; Briody S; Miura T; Fauq I; Oliveros A; Wilson M; Khaniyev S; Williams K; Li Z; Qi Y; Katovich M; Richelson E
    Brain Res; 2010 Jan; 1308():35-46. PubMed ID: 19874804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.
    Roussy G; Beaudry H; Lafrance M; Belleville K; Beaudet N; Wada K; Gendron L; Sarret P
    Neuroscience; 2010 Nov; 170(4):1286-94. PubMed ID: 20727387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
    Smith KE; Boules M; Williams K; Fauq AH; Richelson E
    Behav Brain Res; 2011 Oct; 224(2):344-9. PubMed ID: 21718721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.
    Gonzalez S; Dumitrascuta M; Eiselt E; Louis S; Kunze L; Blasiol A; Vivancos M; Previti S; Dewolf E; Martin C; Tourwé D; Cavelier F; Gendron L; Sarret P; Spetea M; Ballet S
    J Med Chem; 2020 Nov; 63(21):12929-12941. PubMed ID: 32902268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
    Brouillette RL; Besserer-Offroy É; Mona CE; Chartier M; Lavenus S; Sousbie M; Belleville K; Longpré JM; Marsault É; Grandbois M; Sarret P
    Pharmacol Res; 2020 May; 155():104750. PubMed ID: 32151680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells.
    Sarret P; Gendron L; Kilian P; Nguyen HM; Gallo-Payet N; Payet MD; Beaudet A
    J Biol Chem; 2002 Sep; 277(39):36233-43. PubMed ID: 12084713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT
    Previti S; Vivancos M; Rémond E; Beaulieu S; Longpré JM; Ballet S; Sarret P; Cavelier F
    Front Chem; 2020; 8():406. PubMed ID: 32582624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based evolution of subtype-selective neurotensin receptor ligands.
    Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
    ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Wiethe RW; Olepu S; Warner KR; Sarret P; Gendron L; Longpre JM; Zhang Y; Runyon SP; Gilmour BP
    J Med Chem; 2014 Sep; 57(17):7472-7. PubMed ID: 25157640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central delivery of Dicer-substrate siRNA: a direct application for pain research.
    Doré-Savard L; Roussy G; Dansereau MA; Collingwood MA; Lennox KA; Rose SD; Beaudet N; Behlke MA; Sarret P
    Mol Ther; 2008 Jul; 16(7):1331-9. PubMed ID: 18523447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of neurotensin and its analogues in pain.
    Feng YP; Wang J; Dong YL; Wang YY; Li YQ
    Curr Pharm Des; 2015; 21(7):840-8. PubMed ID: 25345606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal NTS2 receptor activation reverses signs of neuropathic pain.
    Tétreault P; Beaudet N; Perron A; Belleville K; René A; Cavelier F; Martinez J; Stroh T; Jacobi AM; Rose SD; Behlke MA; Sarret P
    FASEB J; 2013 Sep; 27(9):3741-52. PubMed ID: 23756650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
    Favre-Guilmard C; Zeroual-Hider H; Soulard C; Touvay C; Chabrier PE; Prevost G; Auguet M
    Eur J Pharmacol; 2008 Oct; 594(1-3):70-6. PubMed ID: 18664366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
    Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
    Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Dmt-D-Lys-Phe-Phe-OH as a highly antinociceptive tetrapeptide metabolite of the opioid-neurotensin hybrid peptide PK20.
    Kleczkowska P; Bojnik E; Leśniak A; Kosson P; Van den Eynde I; Ballet S; Benyhe S; Tourwé D; Lipkowski AW
    Pharmacol Rep; 2013; 65(4):836-46. PubMed ID: 24145077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.
    Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A
    Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.